Kingsview Wealth Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.55M Sell
5,285
-6
-0.1% -$1.59K 0.03% 507
2026
Q1
$580K Sell
5,291
-1,515
-22% -$216K 0.01% 849
2025
Q4
$1.13M Buy
6,806
+729
+12% +$122K 0.02% 603
2025
Q3
$1.19M Buy
6,077
+827
+16% +$136K 0.02% 567
2025
Q2
$475K Sell
5,250
-2,290
-30% -$181K 0.01% 784
2025
Q1
$450K Buy
7,540
+50
+0.7% +$4.63K 0.01% 763
2024
Q4
$992K Buy
7,490
+1,260
+20% +$118K 0.02% 550
2024
Q3
$326K Sell
6,230
-125
-2% -$5.87K 0.01% 858
2024
Q2
$385K Buy
+6,355
New +$441K 0.01% 760

Other funds holding ALAB

Kingsview Wealth Management's ALAB Position: Q2 2026 in Review

Kingsview Wealth Management reduced its Astera Labs (ALAB) stake by 0.11% in Q2 2026, selling an estimated $1.59K and leaving 5,285 shares worth $2.55M. The position accounts for 0.03% of the portfolio, ranked #507.

Kingsview Wealth Management first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Kingsview Wealth Management held 5,285 shares of Astera Labs worth $2.55M as of Q2 2026.
  • Kingsview Wealth Management sold 6 Astera Labs shares in Q2 2026, an estimated $1.59K.
  • Astera Labs made up 0.03% of Kingsview Wealth Management's portfolio in Q2 2026, its #507 holding.
  • Kingsview Wealth Management first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.